Cargando…
Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice
BACKGROUND: Role of immune system in protecting the host from cancer is well established. Growing cancer however subverts immune response towards Th2 type and escape from antitumor mechanism of the host. Activation of both innate and Th1 type response is crucial for host antitumor activity. In our p...
Autores principales: | Ahmad, Faiz, Mani, Jiju, Kumar, Pawan, Haridas, Seenu, Upadhyay, Pramod, Bhaskar, Sangeeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184142/ https://www.ncbi.nlm.nih.gov/pubmed/21984926 http://dx.doi.org/10.1371/journal.pone.0025424 |
Ejemplares similares
-
Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner
por: Kumar, Pawan, et al.
Publicado: (2019) -
Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages
por: Singh, Bindu, et al.
Publicado: (2017) -
Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
por: Gupta, Ankan, et al.
Publicado: (2012) -
Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii
por: Roy, Gargi, et al.
Publicado: (2023) -
Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages
por: Singh, Bindu, et al.
Publicado: (2019)